Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

RushNet Inc (EM) RSHN

Healthcare Industrials Diagnostics & Research Business Services
RushNet, Inc. provides laboratory diagnostic testing services. It offers high-complexity urine drug testing, behavioral drug testing, allergy droplet cards, oral fluids, and infectious disease services. The company is based in Jacksonville, Florida.


EXPM:RSHN - Post by User

RushNet Inc (EM)
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(9)
•••
  • AveragePennyX
Post by AveragePennyon Aug 08, 2022 2:44pm
139 Views
Post# 34879531

heliosDX Responds To Growing Concerns About Monkeypox

heliosDX Responds To Growing Concerns About MonkeypoxALPHARETTA, GA / ACCESSWIRE / August 8, 2022 / RushNet, Inc (OTC PINK:RSHN), (the "Company") is pleased to announce that heliosDX is expanding its Infectious Disease PCR panel to include the Human Monkeypox Virus.

https://www.accesswire.com/711242/heliosdx-responds-to-growing-concerns-about-monkeypox-by-adding-testing-to-its-infectious-disease-panel
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities